
| Timeframe | Typical Results | What's Happening |
|---|---|---|
| Weeks 1–4 | 1–3 lbs lost; reduced appetite | Starting dose; body adjusting, appetite begins to decrease |
| Weeks 5–8 | 3–6 lbs total loss | Dose may increase; hunger and cravings continue to drop |
| Months 3–4 | 5–10% body weight lost | Reaching therapeutic dose range; consistent caloric deficit forms |
| Months 5–6 | 8–12% body weight lost | Full dose; sustained appetite suppression and metabolic benefits |
| Months 9–12 | 12–20%+ body weight lost | Long-term compounding results; significant fat mass reduction |
Many patients lose a meaningful percentage of their body weight over time, especially when they stay consistent with treatment and follow their provider’s plan. Results vary, but GLP-1 injections are generally designed to support gradual, steady weight loss rather than fast short-term drops.
Some people notice reduced appetite and fewer cravings within the first few weeks of treatment. More visible weight loss usually becomes easier to notice over the following months as dosage increases and the medication has more time to work consistently.
Results can last, but long-term success often depends on whether healthy habits are maintained after treatment ends. Some people regain weight after stopping, especially if appetite increases again and the routines built during treatment are not sustained.
Results can vary by person, but semaglutide and tirzepatide are the two most common medications used in GLP-1 programs. Tirzepatide has shown especially strong weight loss results in some studies, although the best option depends on your goals, medical history, and provider recommendation.
The best way to improve results is to stay consistent with treatment and support it with better daily habits. Patients often do better when they focus on protein intake, hydration, activity, sleep, and provider-guided dose adjustments rather than expecting the medication to do everything on its own.




Find more details about GLP-1 Injections.